| News

Biosynex takes up residence in Delémont

26.02.2021

The French company Biosynex develops analytical, diagnostic and prophylactic medical devices. Its portfolio includes a test for COVID-19. It has had a site in Delémont since the start of the year and plans to continue on its growth course from there.

Biosynex founders
Thierry Paper (Deputy Managing Director), Larry Abensur (CEO), Thomas Lamy (Deputy Managing Director)

Biosynex specializes in rapid tests and has launched numerous products for women over recent years, such as fertility tests and pregnancy tests. The French firm with headquarters in Illkirch-Graffenstaden in the Alsace region of France also launched a rapid test for COVID-19 last year, which is being manufactured in France. In order to respond to increasing demand from Switzerland, Biosynex has decided to set up a branch there and is now established in Delémont.

Back in 2018, Fribourg was the original destination for Biosynex’s Swiss branch. However, at the start of 2021, the move was made to Delémont and thus to the Basel Area. According to CEO Larry Abensur, firstly, the proximity to Alsace was one plus point for the location in Jura, but the favorable environment for companies in the life sciences sector in particular, with the “efficient laboratories, academic and private research centers” it provides, was another reason for the new location. In Delémont, Biosynex now not only has the desired infrastructure with offices and storage all in one building, it is also in a position to achieve its new growth targets from its location in Delémont. These have become significantly more ambitious since 2018.

The four acquisitions Biosynex has made over the past four years are testament to this. One such acquisition was of the American company ProciseDx, which develops products for gastroenterology (relating to disorders of the digestive system). Biosynex was founded in 2005 and currently employs over 200 members of staff. Its products are sold in 60 countries.

Share this article

Sign up to receive our newsletter in your inbox.

You may also be interested in

Scailyte now calls Basel home
Basel Area Business & Innovation, Innovation, Invest, Switzerland Innovation Park

Scailyte now calls Basel home

The biotechnology firm Scailyte is now installed at the Novartis Campus of Switzerland Innovation Park Basel Area. Scailyte develops solutions...

Read More
Roche gives MRI equipment a second life
Basel Area Business & Innovation, Innovation, Switzerland Innovation Park

Roche gives MRI equipment a second life

Basel-based pharmaceutical and diagnostics company Roche has decommissioned two MRI machines that are no longer in use. One complete device...

Read More
BGO Software establishes branch in Basel
Basel Area Business & Innovation, Innovation, Invest, Switzerland Innovation Park

BGO Software establishes branch in Basel

The Bulgarian firm BGO Software has now established a presence in Basel after founding BGO Software und Technologie GmbH. The...

Read More
ACM Biosciences receives support for Covid-19 vaccine
Basel Area Business & Innovation, Innovation

ACM Biosciences receives support for Covid-19 vaccine

Innosuisse, the Swiss Innovation Agency, is supporting the Basel-based biotechnology company ACM Biosciences with a grant. This is intended for...

Read More
Basilea receives grant for novel antibiotic
Basel Area Business & Innovation, Innovation, Invest, Switzerland Innovation Park

Basilea receives grant for novel antibiotic

The CARB-X initiative is granting a sum of 2.7 million US dollars to the Basel-based pharmaceuticals company Basilea. This will...

Read More
Discover the Basel Area as #1 in biotech investment
Basel Area Business & Innovation, Innovation, Invest, Switzerland Innovation Park

Discover the Basel Area as #1 in biotech investment

A total of 700+ life science companies call the Basel Area their home. It has become the premier biotech cluster...

Read More
1 2 3 14

Do you have a question? We'd like to hear from you.